Arete Wealth Advisors, LLC Novo Nordisk A S Transaction History

Arete Wealth Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$122.71 - $146.91 $191,918 - $229,767	1,564 Added 13.97%	12,760 $1.82 Million
Q1 2024 May 15, 2024	BUY	$102.11 - $135.92 $283,457 - $377,313	2,776 Added 32.97%	11,196 $1.44 Million
Q4 2023 Feb 14, 2024	BUY	$87.78 - $105.45 $25,456 - $30,580	290 Added 3.57%	8,420 $871,000
Q3 2023 Oct 30, 2023	BUY	$90.94 - $199.54 $618,028 - $1.36 Million	6,796 Added 509.45%	8,130 $739,000
Q2 2023 Aug 09, 2023	SELL	$155.98 - $172.65 $8,578 - $9,495	-55 Reduced 3.96%	1,334 $216,000
Q1 2023 May 01, 2023	BUY	$132.34 - $159.14 $183,820 - $221,045	1,389 New	1,389 $221,000

1,955

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $246B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Arete Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Arete Wealth Advisors, LLC with notifications on news.